🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, claiming the firms withheld potential risks that the drug created to children's brain development.

This legal action comes a month after Donald Trump publicized an unsubstantiated connection between taking acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the only pain reliever recommended for women during pregnancy, and Kenvue, which currently produces it.

In a statement, he said they "deceived the public by profiting off of discomfort and promoting medication ignoring the risks."

The company says there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These corporations lied for decades, deliberately risking millions to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the health of US mothers and children."

On its official site, Kenvue also said it had "continuously evaluated the applicable studies and there is lacking reliable evidence that shows a verified association between using paracetamol and autism."

Associations acting on behalf of doctors and health professionals concur.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can present major wellness concerns if ignored.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of acetaminophen in any period of gestation results in neurodevelopmental disorders in offspring," the group stated.

The court filing references current declarations from the former administration in arguing the drug is allegedly unsafe.

Recently, Trump caused concern from public health officials when he advised women during pregnancy to "fight like hell" not to consume Tylenol when ill.

Federal regulators then released a statement that doctors should consider limiting the use of Tylenol, while also mentioning that "a direct connection" between the drug and autism in children has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had promised in spring to initiate "a massive testing and research effort" that would establish the cause of autism in a matter of months.

But experts advised that identifying a single cause of autism - believed by scientists to be the result of a complex mix of inherited and environmental factors - would be difficult.

Autism is a form of enduring cognitive variation and disability that affects how persons perceive and relate to the surroundings, and is identified using medical professional evaluations.

In his court filing, the attorney general - aligned with the former president who is seeking the Senate - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the science" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the firms "eliminate any commercial messaging" that asserts Tylenol is reliable for pregnant women.

This legal action echoes the complaints of a collection of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in 2022.

A federal judge threw out the case, saying studies from the plaintiffs' authorities was not conclusive.